The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Nitric oxide for respiratory failure in infants born at or near term
Open accessAbstract
BACKGROUND: Nitric oxide (NO) is a major endogenous regulator of vascular tone. Inhaled nitric oxide (iNO) gas has been investigated as treatment for persistent pulmonary hypertension of the newborn. OBJECTIVES: To determine whether treatment of hypoxaemic term and near-term newborn infants with iNO improves oxygenation and reduces rate of death and use of extracorporeal membrane oxygenation (ECMO), or affects long-term neurodevelopmental outcomes. SEARCH METHODS: We used the standard search strategy of the Cochrane Neonatal Review Group to search the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 1), MEDLINE via PubMed (1966 to January 2016), Embase (1980 to January 2016) and the Cumulative Index to Nursing and Allied Health Literature (CINAHL; 1982 to January 2016). We searched clinical trials databases, conference proceedings and reference lists of retrieved articles for randomised controlled trials and quasi-randomised trials. We contacted the principal investigators of studies published as abstracts to ascertain the necessary information. SELECTION CRITERIA: Randomised studies of iNO in term and near-term infants with hypoxic respiratory failure, with clinically relevant outcomes, including death, use of ECMO and oxygenation. DATA COLLECTION AND ANALYSIS: We analysed trial reports to assess methodological quality using the criteria of the Cochrane Neonatal Review Group. We tabulated mortality, oxygenation, short-term clinical outcomes (particularly use of ECMO) and long-term developmental outcomes. STATISTICS: For categorical outcomes, we calculated typical estimates for risk ratios and risk differences. For continuous variables, we calculated typical estimates for weighted mean differences. We used 95% confidence intervals and assumed a fixed-effect model for meta-analysis. MAIN RESULTS: We found 17 eligible randomised controlled studies that included term and near-term infants with hypoxia.Ten trials compared iNO versus control (placebo or standard care without iNO) in infants with moderate or severe severity of illness scores (Ninos 1996; Roberts 1996; Wessel 1996; Davidson 1997; Ninos 1997; Mercier 1998; Christou 2000; Clark 2000; INNOVO 2007; Liu 2008). Mercier 1998 compared iNO versus control but allowed back-up treatment with iNO for infants who continued to satisfy the same criteria for severity of illness after two hours. This trial enrolled both preterm and term infants but reported most results separately for the two groups. Ninos 1997 studied only infants with congenital diaphragmatic hernia.One trial compared iNO versus high-frequency ventilation (Kinsella 1997).Six trials enrolled infants with moderate severity of illness scores (oxygenation index (OI) or alveolar-arterial oxygen difference (A-aDO2)) and randomised them to immediate iNO treatment or iNO treatment only after deterioration to more severe criteria (Barefield 1996; Day 1996; Sadiq 1998; Cornfield 1999; Konduri 2004; Gonzalez 2010).Inhaled nitric oxide appears to have improved outcomes in hypoxaemic term and near-term infants by reducing the incidence of the combined endpoint of death or use of ECMO (high-quality evidence). This reduction was due to a reduction in use of ECMO (with number needed to treat for an additional beneficial outcome (NNTB) of 5.3); mortality was not affected. Oxygenation was improved in approximately 50% of infants receiving iNO. The OI was decreased by a (weighted) mean of 15.1 within 30 to 60 minutes after the start of therapy, and partial pressure of arterial oxygen (PaO2) was increased by a mean of 53 mmHg. Whether infants had clear echocardiographic evidence of persistent pulmonary hypertension of the newborn (PPHN) did not appear to affect response to iNO. Outcomes of infants with diaphragmatic hernia were not improved; outcomes were slightly, but not significantly, worse with iNO (moderate-quality evidence).Infants who received iNO at less severe criteria did not have better clinical outcomes than those who were enrolled but received treatment only if their condition deteriorated. Fewer of the babies who received iNO early satisfied late treatment criteria, showing that earlier iNO reduced progression of the disease but did not further decrease mortality nor the need for ECMO (moderate-quality evidence). Incidence of disability, incidence of deafness and infant development scores were all similar between tested survivors who received iNO and those who did not. AUTHORS' CONCLUSIONS: Inhaled nitric oxide is effective at an initial concentration of 20 ppm for term and near-term infants with hypoxic respiratory failure who do not have a diaphragmatic hernia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Inhaled Nitric Oxide for the Adult Respiratory Distress Syndrome
Rossaint, R., Falke, K. J., Lopez, F., Slama, K., Pison, U., & Zapol, W. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302113280605 · Cited by 1,811
Palmer, R. M. J., Rees, D. D., Ashton, D. S., & Moncada, S. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81362-7 · Cited by 1,349
Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction
Frostell, C., Fratacci, M. D., Wain, J. C., Jones, R., & Zapol, W. M. (1991) · Circulation · doi:10.1161/01.cir.83.6.2038 · Cited by 1,128
Published by John Wiley & Sons Ltd
Modarresi, O. A. F., & Shakibaie, M. M. M. R. (2015) · Cited by 1,111
Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
PEPKEZABA, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)92033-x · Cited by 1,055
Inhaled Nitric Oxide in Full-Term and Nearly Full-Term Infants with Hypoxic Respiratory Failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360901 · Cited by 865
Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
ROBERTS, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)92686-a · Cited by 863
Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn
Roberts, J. D., Fineman, J. R., Morin, F. C., Shaul, P. W., Rimar, S., Schreiber, M. D., Polin, R. A., Zwass, M. S., Zayek, M. M., Gross, I., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360902 · Cited by 804
Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn
Clark, R. H., Kueser, T. J., Walker, M. W., Southgate, W. M., Huckaby, J. L., Perez, J. A., Roy, B. J., Keszler, M., & Kinsella, J. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002173420704 · Cited by 731
Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
KINSELLA, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)92687-b · Cited by 730
Endothelium-derived relaxing factor
Moncada, S., Radomski, M. W., & Palmer, R. M. J. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90236-5 · Cited by 676
Gruetter, C. A., Gruetter, D. Y., Lyon, J. E., Kadowitz, P. J., & Ignarro, L. J. (1981) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32778-3 · Cited by 533
Inhaled Nitric Oxide and Hypoxic Respiratory Failure in Infants With Congenital Diaphragmatic Hernia
The Neonatal Inhaled Nitric Oxide Study Group (NINOS) (1997) · Pediatrics · doi:10.1542/peds.99.6.838 · Cited by 455
Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth
Abman, S. H., Chatfield, B. A., Hall, S. L., & McMurtry, I. F. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.259.6.h1921 · Cited by 444
GERLACH, H., ROSSAINT, R., PAPPERT, D., & FALKE, K. J. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00797.x · Cited by 404
Davidson, D., Barefield, E. S., Kattwinkel, J., Dudell, G., Damask, M., Straube, R., Rhines, J., Chang, C.-T., & the I-NO/PPHN Study Group (1998) · Pediatrics · doi:10.1542/peds.101.3.325 · Cited by 354
Kinsella, J. P., Neish, S. R., Ivy, D. D., Shaffer, E., & Abman, S. H. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)81551-3 · Cited by 332
Wennmalm, Å., Benthin, G., & Petersson, A. ‐. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb14365.x · Cited by 296
Fratacci, M.-D., Frostell, C. G., Chen, T.-Y., Wain, J. C., Robinson, D. R., & Zapol, W. M. (1991) · Anesthesiology · doi:10.1097/00000542-199112000-00011 · Cited by 281
Ignarro, L. J., Adams, J. B., Horwitz, P. M., & Wood, K. S. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89205-0 · Cited by 271
Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: Dose response
Finer, N. N., Etches, P. C., Kamstra, B., Tierney, A. J., Peliowski, A., & Ryan, C. A. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70324-8 · Cited by 268
Self-citationBleeding time prolongation and NO inhalation
HOGMAN, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)90802-n · Cited by 236
Mechanisms of peroxynitrite-induced injury to pulmonary surfactants
Haddad, I. Y., Ischiropoulos, H., Holm, B. A., Beckman, J. S., Baker, J. R., & Matalon, S. (1993) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1993.265.6.l555 · Cited by 232
Regulation of Vascular Homeostasis by Nitric Oxide
Radomski, M. W., & Moncada, S. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646156 · Cited by 228
Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system
Walter, U. (2005) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/bfb0032675 · Cited by 221
Nitric oxide for respiratory failure in infants born at or near term
Finer, N., & Barrington, K. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000399.pub2 · Cited by 207
Self-citationInhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb.
Roberts, J. D., Chen, T. Y., Kawai, N., Wain, J., Dupuy, P., Shimouchi, A., Bloch, K., Polaner, D., & Zapol, W. M. (1993) · Circulation Research · doi:10.1161/01.res.72.2.246 · Cited by 201
WESSEL, D. L., Adatia, I., Marter, L. J. V., Thompson, J. E., Kane, J., Stark, A. R., & Kourembanas, S. (1997) · PEDIATRICS · doi:10.1542/peds.100.5.e7 · Cited by 160
✲ (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.104826 · Cited by 160
Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange
Pison, U., Lopez, F. A., Heidelmeyer, C. F., Rossaint, R., & Falke, K. J. (1993) · Journal of Applied Physiology · doi:10.1152/jappl.1993.74.3.1287 · Cited by 159
Nitric oxide for respiratory failure in infants born at or near term
Finer, N., & Barrington, K. (2001) · The Cochrane Database of Systematic Reviews (Complete Reviews) · doi:10.1002/14651858.cd000399 · Cited by 158
Self-citationMercier, J., Thébaud, B., ONODY, P., Storme, L., OVERMEIRE, B. V., Bréart, G., DEHAN, M., Gold, F., DOYON, F., Pons, G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03309-7 · Cited by 155
Biotransformation of Nitric Oxide
Yoshida, K., & Kasama, K. (1987) · Environmental Health Perspectives · doi:10.1289/ehp.8773201 · Cited by 127
Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation
Kinsella, J. P., McQueston, J. A., Rosenberg, A. A., & Abman, S. H. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.3.h875 · Cited by 126
Konduri, G. G., Vohr, B. R., Robertson, C. M. T., Sokol, G. M., Solimano, A. J., Singer, J., Ehrenkranz, R. A., Singhal, N., Wright, L. L., Meurs, K. P. V., et al. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2006.11.065 · Cited by 115
EFFECTS OF HIGHER OXIDES OF NITROGEN ON THE ANAESTHETIZED DOG
GREENBAUM, R., BAY, J., HARGREAVES, M. D., Kain, M. L., Kelman, G., NUNN, J. F., Roberts, C. P., & SIEBOLD, K. (1967) · British Journal of Anaesthesia · doi:10.1093/bja/39.5.393 · Cited by 106
Prolonged bleeding time during nitric oxide inhalation in the rabbit
Högman, M., Frostell, C., Arnberg, H., Sandhagen, B., & Hedenstierna, G. (1994) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1994.tb09728.x · Cited by 106
Christou, H. A., Marter, L. J. V., WESSEL, D. L., Allred, E. N., Kane, J., Thompson, J. E., Stark, A. R., & Kourembanas, S. (2000) · Critical Care Medicine · doi:10.1097/00003246-200011000-00031 · Cited by 101
Lowson, S. M., Rich, G. F., McArdle, P. A., Jaidev, J., & Morris, G. N. (1996) · Anesthesia & Analgesia · doi:10.1097/00000539-199603000-00026 · Cited by 82
Safety requirement for use of inhaled nitric oxide in neonates
Bouchet, M., Renaudin, M.-H., Raveau, C., Mercier, J., Dehan, M., & Zupan, V. (1993) · The Lancet · doi:10.1016/0140-6736(93)91267-p · Cited by 82
Hoffman, G. M., Ross, G. A., Day, S. E., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199702000-00026 · Cited by 73
The pharmacology of inhaled nitric oxide.
Edwards, A. D. (1995) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/fn.72.2.f127 · Cited by 38
Field, D. J., Elbourne, D. R., Hardy, P., Fenton, A. C., Ahluwalia, J. S., Halliday, H. L., Subhedar, N. V., Heinonen, K., Aikio, O., Grieve, R., et al. (2006) · Neonatology · doi:10.1159/000097123 · Cited by 28
Cited by
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.013 · Cited by 1,881
Brok, J., Thorlund, K., Gluud, C., & Wetterslev, J. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.10.007 · Cited by 1,113
Brok, J., Thorlund, K., Wetterslev, J., & Gluud, C. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn188 · Cited by 917
PDE5 inhibitors – pharmacology and clinical applications 20 years after sildenafil discovery
Andersson, K. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14205 · Cited by 445
Inhaled nitric oxide for respiratory failure in preterm infants
Barrington, K. J., Finer, N., & Pennaforte, T. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000509.pub5 · Cited by 360
Self-citation
Metadata
- Authors
- Barrington, K. J., Finer, N., Pennaforte, T., & Altit, G.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-01-05
- Volume
- 2017
- Issue
- 1
- Pages
- CD000399-CD000399
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1597886774
- Cited by
- 528
- References
- 46
- FWCI
- 20.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.